SPY422.60-0.51 -0.12%
DIA338.78-0.67 -0.20%
IXIC14,271.73+18.47 0.13%

Mizuho Maintains Buy on Biohaven Pharma Hldgs, Lowers Price Target to $90

Mizuho analyst Vamil Divan maintains Biohaven Pharma Hldgs (NYSE:BHVN) with a Buy and lowers the price target from $98 to $90.

05/11/2021 10:43
Mizuho analyst Vamil Divan maintains Biohaven Pharma Hldgs (NYSE:BHVN) with a Buy and lowers the price target from $98 to $90.